SCHEMBL238548

SCHEMBL238548

CC(=O)NNC(=S)Nc1cccc(Cl)c1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.66
LMNA P02545 2/20 0.66
KDM4E B2RXH2 2/20 0.66
POLB P06746 1/20 0.66
KMT2A Q03164 8/20 0.57
MEN1 O00255 7/20 0.57
MAPT P10636 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
HTT P42858 1/20 0.56
HPGD P15428 2/20 0.54
PLA2G1B P04054 1/20 0.54
BLM P54132 1/20 0.54
ATG4B Q9Y4P1 1/20 0.54
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11537313 0.87 NPC1 (0.68) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL11536532 0.82 GAA (0.54) ALDH1A1LMNAKDM4EPOLBNPC1
SCHEMBL6816495 0.82 ALDH1A1 (0.84) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL30623497 0.81 MEN1 (0.67) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL3612815 0.81 MEN1 (0.67) ALDH1A1LMNAKDM4EPOLBKMT2A
Hydrochloric Acid SCHEMBL28564415 0.80 MEN1 (0.65) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL21972741 0.79 ALDH1A1 (0.62) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL11541462 0.78 ALDH1A1 (0.58) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL3606616 0.78 ALDH1A1 (0.56) ALDH1A1LMNAKDM4EPOLBKMT2A
SCHEMBL11533636 0.75 ALDH1A1 (0.66) ALDH1A1LMNAKDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097394-B1 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS ESTEVE LABOR DR (ES) 2013-12-25 EP disclosed
US-8349878-B2 1,2,4-triazole derivatives as sigma receptor inhibitors LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-01-08 US disclosed
CN-101595098-B 1,2,4-triazole derivatives as sigma receptor inhibitors ESTEVE LABOR DR 2012-07-18 CN disclosed
US-20120004211-A1 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-01-05 US disclosed
US-8039497-B2 1,2,4-triazole derivatives as sigma receptor inhibitors LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-10-18 US disclosed
US-20100004224-A1 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-01-07 US disclosed
CN-101595098-A As 1,2 of sigma receptor inhibitors, the 4-triazole derivative ESTEVE LABOR DR (ES) 2009-12-02 CN disclosed
EP-1921073-A1 1,2,4-Triazole derivatives as sigma receptor inhibitors Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004224-A1 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS SIGMAR1, TMEM97, OPRK1 ALDH1A1 704/4885LMNA 4239/4885KDM4E 4136/4885
US-20120004211-A1 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS SIGMAR1, TMEM97, OPRK1 ALDH1A1 705/4885LMNA 4083/4885KDM4E 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.